TRƯỜng đẠi học khoa học tự nhiêN

TÀI LIỆU THAM KHẢO

1. 
   Trương Thị Huệ, Nguyễn Văn Liệu, Phạm Vân Anh, Nguyễn Thị Vân Anh, Phan Tuấn Nghĩa (2012), “Phát hiện và định lượng đột biến A3243G trong hệ gen ty thể ở hội chứng MELAS”, Tạp chí công nghệ sinh học, 10(3), tr. 423-429.
   
2. 
   Phùng Bảo Khánh, Nguyễn Văn Minh, Trần Đức Hiệp, Trần Kiều Anh, Trương Thị Huệ, Phạm Vân Anh, Lê Ngọc Anh, Cao Vũ Hùng, Phan Tuấn Nghĩa (2015), “Phát hiện đột biến gen ty thể A1555G gây bệnh điếc cảm ứng bởi Aminoglycoside ở một số bệnh nhân người Việt Nam”, Tạp chí Khoa học ĐHQGHN – Khoa học Tự Nhiên và Công nghệ , 31(3), tr. 1-7.
   
3. 
   Nguyễn Văn Minh, Phùng Bảo Khánh, Trương Thị Huệ, Cao Vũ Hùng, Phạm Vân Anh, Nguyễn Thị Hồng Loan, Phan Tuấn Nghĩa (2015), “Sàng lọc đột biến G3460A, G11778A và phát hiện đột biến mất đoạn 6 bp mới trên hệ gen ty thể bệnh nhân thần kinh cơ Việt Nam”, Tạp chí Công nghệ Sinh học, 13(2), tr. 1-7.
   
4. 
   Trịnh Lê Phương, Chu Văn Mẫn, Phan Tuấn Nghĩa (2009), “Phát hiện đột biến gen A3243G của hội chứng MELAS bằng phương pháp PCR-RFLP cải tiến”, Tạp chí Di truyền và ứng dụng, 4, tr. 6-9.
   
5. 
   Phạm Hùng Vân (2009), PCR và real-time PCR – Các vấn đề cơ bản và các áp dụng thường gặp, Nhà xuất bản Y học, Hà Nội.
   

6. 
   Abbott J. A., Francklyn C. S., Robey-Bond S. M. (2014), “Transfer RNA and human disease”, Frontiers in Genetics, 5(158), pp. 1-18.
   
7. 
   Abreu-Silva R. S., Lezirovitz K., Braga M. C. C., Spinelli M., Pirana S., Della-Rosa V. A., Otto P. A., Mingroni-Netto R. C. (2006), “Prevalence of the A1555G (12S rRNA) and tRNA^Ser (UCN) mitochondrial mutations in hearing-impaired Brazilian patients”, Brazilian Journal of Medical and Biological Research, 39, pp. 219-226.
   
8. 
   Bai R. K., Wong L. J. C. (2004), “Detection and quantification of heteroplasmic mutant mitochondrial DNA by real-time amplification refractory mutation system quantitative PCR analysis: A single-step approach”, Clinical Chemistry, 50, pp. 996-1001.
   
9. 
   Berdanier C. D. (2005), Mitochondria in healthy and disease, CRC Press.
   
10. 
    Blakely L. E., Alston L. C., Lecky B., Chakrabart B., Falkous G., Turnbull M. D., Taylor W. R., Gorman S. G. (2014), “Distal weakness with respiratory insufficiency caused by the m.8344A > G “MERRF” mutation”, Science Direct, 24, pp. 533–536.
    
11. 
    Blasiak J., Glowacki S., Kauppinen A., Kaarniranta K. (2013), “Mitochondrial and Nuclear DNA Damage and Repair in Age-Related Macular Degeneration”, International Journal of Molecular Sciences, 14(2), pp. 2996-3010.
    
12. 
    Bornsttein B., Mas J. A., Patrono. C., Fernández-Moreno M. A., González-Vioque E., Campos. Y., Carrozzo. R., Martín. M. A., Del Hoyo . P., Santorelli. F. M., Arenas J., Garesse R. (2005), “Comparative analysis of the pathogenic mechanisms associated with the G8363A and A8296G mutations in the mitochondrial tRNA ^Lys gene”, Biochemical Journal, 387, pp. 773–77.
    
13. 
    Boulet L., Karpati G., Shoubridge E. A. (1992) “Distribution and threshold expression of the tRNA-lys mutation in skeletal muscle of patients with myoclonic epilepsy and ragged-red fibers (MERRF)”, The American Journal of Human Genetics, 51(6), pp. 1187 - 1200.
    
14. 
    Burgstaller J. P., Johnston I. G., Poulton J. (2015), “Mitochondrial DNA disease and developmental implications for reproductive strategies”, Molecular Human Reproduction, 21(1), pp.11-22.
    
15. 
    Calabresi P. A., Silvestri G., Dimauro S., Grigga R. C. (1994), “Ekbom’s syndrome: Lipomas, ataxia, and neuropathy with MERRF”, Muscle and Nerve, 17, pp. 943-945.
    
16. 
    Cao Y., Ma Y., Zhang Y., Li Y., Fang F., Wang S., Bu D., Xu Y., Pei P., Li L., Xiao Y., Wua H, Yang Y., Zou L., Qi Y. (2010), “Detection of eight frequently encountered point mutations in mitochondria in Chinese patients suggestive of mitochondrial encephalomyopathies”, Mitochondrion, 10, pp. 330-334.
    
17. 
    Chong J. W., Annuar A. A, Wong W. T., Thong M. K., Goh K. J. (2014), “Single mitochondrial DNA deletions in chronic progressive external ophthalmoplegia (CPEO) and Kearns-Sayre syndrome (KSS) patients from a multiethnic Asian population”, Neurology Asia, 19(1), pp. 27-36.
    
18. 
    Cohen H. B. (2013), “Neuromuscular and Systemic Presentations in Adults: diagnoses beyond MERRF and MELAS”, Neurotherapeutics, 10, pp. 227–242.
    
19. 
    Craven L., Tuppen H. A., Greggains G. D., Harbottle S. J., Julie L., Murphy, Cree L. M., Murdoch A. P., Chinnery P. F., Taylor R. W., Lightowlers R. N., Herbert M., Turnbull D. M. (2010), “Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease”, Nature, 465(7294), pp. 82-85.
    
20. 
    De la Mata M., Garrido-Maraver J., Cotán D., Cordero M. D., Oropesa-Ávila M., Izquierdo L. G., De Miguel M., Lorite J. B., Infante E. R., Ybot P., Jackson S., Sánchez-Alcázar J. A. (2012), “Recovery of MERRF Fibroblasts and Cybrids Pathophysiology by Coenzyme Q₁₀”, Neurotherapeutics, 9, pp. 446-463.
    
21. 
    Detmer S. A., Chan D. C. (2007), “Functions and dysfunctions of mitochondrial dynamics”, Nature Publishing Group, 8, pp. 870-879.
    
22. 
    Duchen M. R. (2004), “Roles of Mitochondria in Health and Disease”, Diabetes, 53, pp. 96-102.
    
23. 
    Duchen M. R., Szabadkai G. (2010), “Role of mitochondria in human disease”, Essay in Biochemistry, 47, pp. 118-136.
    
24. 
    El-Hattab A. W., Scaglia F. (2013), “Mitochondrial DNA Depletion Syndromes: Review and Updates of Genetic Basis, Manifestations, and Therapeutic Options”, Neurotherapeutics, 10, pp. 186-198.
    
25. 
    Emmanuele V., Silvers D. S., Sotiriou E., Tanji K., DiMauro S., Hirano M. (2011), “MERRF and Kearns-Sayre overlap syndrome due to the mtDNA m.3291T>C mutation”, Muscle Nerve., 44(3), pp. 448–451.
    
26. 
    Fan H., Civalier C., Booker J. K., Gulley M. L., Prior T. W., Farber R. A. (2006), “Detection of common disease-causing mutations in mitochondrial DNA (Mitochondrial encephalomyopathy, lactic acidosis with stroke-like episodes MTTL1 A3243G and myoclonic epilepsy associated with ragged-red fibers MTTK A8344G) by real-time polymerase chain reaction”, Journal of Molecular Diagnostics, 8, pp. 277-281.
    
27. 
    Fawcett D. W. (1981), The Cell, W. B. Saunders Company, NewYork.
    
28. 
    Fukuhara N., Tokiguchi S., Shirakawa K., Tsubaki T. (1980), “Myoclonus epilepsy associated with ragged-red fibers (mitochondrial abnormalities) disease entity or a syndrome”, Journal Neurol Science, 4791, pp. 117-133.
    
29. 
    Giles R. E. (1980), “Maternal inheritance of human mitochondria DNA”, Genetics, 77, pp. 6715-6719.
    
30. 
    Graf W.D., Sumi S. M., Copass M. K., Ojemann L. M., Longstreth W. T., Shanske S., Lombes A., DiMauro S. (1993), “Phenotypic Heterogeneity in families with the Myoclonic Epilepsy and Ragged-Red Fiber Disease Point Mutation in Mitochondrial DNA”, American Neurological Association, 33, pp. 640-645.
    
31. 
    Greaves L. C., Reeve A. K., Taylor R. W., Turnbull D. M. (2012) “Mitochondrial DNA and disease”, The Journal of Pathology, 226, pp. 274-286
    
32. 
    Green R. D., Reed C. J. (1998), “Mitochondria and apoptosis”, Science, 281, pp. 1309 – 1311.
    
33. 
    Hammans S. R., Sweeney M. G., Brockington M., Lennox G. G., Lawton N. F., Kennedy C. R., Morgan-Hughes J. A., Harding A. E. (1993), “The mitochondrial DNA transfer RNA^Lys AG⁽⁸³⁴⁴⁾ mutation and the syndrome of myoclonic epilepsy with ragged red fibres (MERRF): Relationship of clinical phenotype to proportion of mutant mitochondrial DNA”, Brain,116, pp. 617-632.
    
34. 
    Jeong S. Y., Seol D. W. (2007), “The role of mitochondria in apoptosis”, B. M. B. reports, pp. 11-22.
    
35. 
    Krauss S. (2001), “Mitochondria: Structure and Role in Respiration”, Encyclopedia of Life Sciences, pp. 1- 6.
    
36. 
    Kwon S. J., Park S. S., Kim J. M., Ahn T. B., Kim S. H., Kim J., Lee S. H., Ha C. K., Ahn M. Y., Jeon B. S. (2004), “Investigation of common mitochondrial point mutations in Korea”, Genes and apoptosis to aging and disease, 1011, pp. 339-344.
    
37. 
    Lorenzoni P. J., Scola R. H., Kay C. S. K., Silvado C. E. S., Werneck L. C. (2014), “When should MERRF (myoclonus epilepsy associated with ragged-red fibers) be the diagnosis?”, Arquivos Neuro-psiquiatria (tên đầy đủ), 72(10), pp. 803-881.
    
38. 
    Masucci J. P., Davidson M., Koga Y., Schon E. A., King A. P. (1995), “In Vitro Analysis of Mutations Causing Myoclonus Epilepsy with Ragged-Red Fibers in the Mitochondrial tRNA ^Lys Gene: Two Genotypes Produce Similar Phenotypes”, Molecular Cellular Biology, 15(5), pp. 2872-2881.
    
39. 
    Mfinschef C., Rieger T., Miiller-Huckerb J., Kadenbach B. (1993), “The point mutation of mitochondrial DNA characteristic for MERRF disease is found also in healthy people of different ages”, Federation of European Biochemical Societies letters, 317(1), pp. 27-30.
    
40. 
    Mimaki M., Hatakeyama H., Ichiyama T., Isumi H., Furukawa S., Akasaka M., Kamei A., Komaki H., Nishino I., Nonaka I., Goto Y. (2009), “Different effects of novel mtDNA G3242A and G3244A base changes adjacent to a common A3243G mutation in patients with mitochondrial disorders”, Mitochondrion, 9(2), pp. 115-122.
    
41. 
    Musumeci O., Andreu A. L., Shanske S., Bresolin N., Comi G. P., Rothstein R., Schon E. A., DiMauro S. (2000), “Intragenic inversion of mtDNA: A new type of pathogenic mutation in a patient with mitochondrial myopathy”, The American Journal of Human Genetics, 66, pp. 1900-1904.
    
42. 
    Noer A. S., Sudoyo H., Lertrit P., Thyagarajan D., Utthanaphol P., Kapsa R., Byrnet E., Marzuki S. (1991), “A tRNA^Lys Mutation in the mtDNA is the Causal Genetic Lesion Underlying Myoclonic Epilepsy and Ragged-Red Fiber (MERRF) Syndrome”, The American Society of Human Genetics, 49, pp. 715-722.
    
43. 
    Pulkes T., Hanna M. G. (2001), “Human mitochondrial DNA diseases”, Advanced Drug Delivery Reviews, 49, pp. 27-43.
    
44. 
    Qi Y., Zhang Y., Wang Z., Yang Y., Yuan Y., Niu S., Pei P., Wang S., Ma Y., Bu D., Zou L., Fang F., Xiao J., Sun F., Zhang Y., Wu Y., Wang S., Xiong H., Wu X. (2006), “Screening of common mitochondrial mutations in Chinese patients with mitochondrial encephalomyopathies”, Mitochondrion, 7, pp. 147-150.
    
45. 
    Santorelli F. M., Mak S. C., El-Schahawi M., Casali C., Shanske S., Baram T. Z., Madrid R. E., DiMauro S. (1996), “ Maternally Inherited Cardiomyopathy and Hearing Loss Associated with a Novel Mutation in the Mitochondrial tRNA1LY Gene (G8363A)”, The American Journal of Human Genetics, 58, pp. 933-939.
    
46. 
    Sato M., Sato K. (2013), “Maternal inheritance of mitochondrial DNA by diverse mechanisms to eliminate paternal mitochondrial DNA”, Biochimica et Biophysica Acta, 1833, pp. 1979-1984.
    
47. 
    Seibel P., Degoul F., Bonne G., Romero N., Frangois D., Paturneau-Jouas M., Ziegler F., Eymard B., Fardeau M., Marsac C., Kadenbach B. (1991), “Genetic biochemical and pathophysiological characterization of a familial mitochondrial encephalomyopathy (MERRF)”, Journal of the Neurological Sciences, 105, pp. 217-224.
    
48. 
    Sena L. A., Chandel N. S. (2012), “Physiological roles of mitochondrial reactive oxygen species”, Molecular Cell, 48(2), pp. 158-167.
    
49. 
    Shanske S., Goodman S., Sue C. M., Bruno C., Johnson T. L., Lava N. S., Waheed N., DiMauro S. (2000), “G8363A mutation in the mitochondrial DNA transfer ribonucleic acid Lys gene: another cause of Leigh syndrome”, Journal of Child Neurology, 15(11), pp. 759-761.
    
50. 
    Shoffner J. M., Wallace D. C. (1992), “Mitochondrial Genetics: Principles and Practice”, The American Journal of Human Genetics, 51, pp. 179-1186.
    
51. 
    Silvestri G., Moraes C. T. , Shanske S., Oh S. J., DiMauro S. (1992), “A New mtDNA Mutation in the tRNA ^Lys Gene Associated with Myoclonic Epilepsy and Ragged-Red Fibers (MERRF)”, The American Journal of Human Genetics, 51, pp. 1213-1217.
    
52. 
    Szuhai K., Ouweland J. M., Dirks R. W., Lemaître M., Truffert J. C., Janssen J. M., Tanke H. J., Holme E., Maassen J. A., Raap A. K. (2001), “Simultaneous A8344G heteroplasmy and mitochondrial DNA copy number quantification in Myoclonus Epilepsy and Ragged-Red Fibers (MERRF) syndrome by a multiplex Molecular Beacon based real-time fluorescence PCR”, Nucleic Acids Research, 29(3), pp. 1-6.
    
53. 
    Taylor R. W., Morris A. A. M., Hutchinson M., Turnbull D. M. (2002), “Leigh disease associated with a novel mitochondrial DNA ND5 mutation”, European Journal of Human Genetics, 10, pp. 141-144.
    
54. 
    Taylor R. W., Turnbull D. M. (2007), “Mitochondrial DNA mutations in human disease”, Nature Review Genetics, 6(5), pp. 389-402.
    
55. 
    Truong T. H., Nguyen T. V. A., Nguyen V. L., Pham V. A., Phan T. N. (2014), “Screening of common point-mutations and discovery of new T14727C change in mitochondrial genome of Vietnamese encephalomyopathy patients”, Mitochondrial DNA, 27, pp. 441-448.
    
56. 
    Tuppen H. A., Blakely E. L., Turnbull D. M., Taylor R. W. (2010), “Mitochondrial DNA mutations and human disease”, Biochimica et Biophysica Acta, 1797, pp. 113–128.
    
57. 
    Virgilio R., Ronchi D., Bordoni A., Fassone E., Bonato S., Donadoni C., Torgano G., Moggio M., Corti S., Bresolin N., Comi G. P. (2009), “Mitochondrial DNA G8363A mutation in the tRNA Lys gene: clinical, biochemical and pathological study”, Journal Neurol Science, 281(1-2), pp. 85-92.
    
58. 
    Wallace C. D. (2012), “Mitochondria and cancer”, Nature Reviews Cancer, 12(10), pp. 685–698.
    
59. 
    Wallace C. D., Chalkia D. (2013), “Mitochondrial DNA Genetics and the Heteroplasmy Conundrum in Evolution and Disease”, Cold Spring Harbor Perspectives in Biology, 5, pp. 1-47.
    
60. 
    Wang Z., Cai F., Chen X., Luo M., Hu L., Lu Y. (2013), “The Role of Mitochondria-Derived Reactive Oxygen Species in Hyperthermia-Induced Platelet Apoptosis”, Plos one, 8(9), pp. 1-14.
    
61. 
    Wong L. J. C. (2012), “Mitochondrial Disorders Biochemical and Molecular Analysis”, Human Express, Part 1, pp. 3-46.
    
62. 
    Yao Y. G., Watkins W. S., Zhang Y. P. (2000), “Evolutionary history of the mtDNA 9-bp deletion in Chinese populations and its relevance to the peopling of east and southeast Asia”, Human Genetics, 107, pp. 504-512.
    
63. 
    Zhang Y., Yang Y. L., Sun F., Cai X., Qian N., Yuan Y., Wang Z. X., Qi Y., Xiao J. X., Wang X. Y., Zhang Y. H., Jiang Y. W., Qin J., Wu X. R. (2007), “Clinical and molecular survey in 124 Chinese patients with Leigh or Leigh-like syndrome”, Journal of Inherited Metabolic Disease, 30(2), pp. 265-267.
    

64. 
    http://www.ncbi.nlm.nih.gov/pubmed
    
65. 
    http://ghr.nlm.nih.gov/condition/pearson-marrow-pancreas-syndrome
    
66. 
    http://www.ncbi.nlm.nih.gov/books/NBK1173/
    
67. 
    http://www.pnas.org/content/105/11/4441/F1.expansion.html
    
68. 
    http://www.ncbi.nlm.nih.gov/books/NBK9896/
    
69. 
    https://www.orpha.net/data/patho/GB/uk-LHON
    
70. 
    http://www.ncbi.nlm.nih.gov/books/NBK1520/
    
71. 
    http://www.ngrl.org.uk/Wessex